Regardless of the controversy surrounding the predictive and prognostic value of VEGF in ovarian cancer, our study showed that the prognostic value of the panel of the 25 factors was superior to that of VEGF alone, supporting the potential of our method. The gene discussed is VEGFA; the disease is ovarian carcinoma.